Alan
Paris, France · StartupModern health insurance platform streamlining getting care for European employees.
StartupGrowthHealthSoftware
Incubator
Station F
Opened in 2017, Station F is a large startup campus and incubator in a converted rail depot hosting 1,000+ startups through themed programs and events. Scope: National & international.
Support: co-working, on-site accelerators, investor and partner network.
FranceParisCross-sector
Details
Location
Paris, France
Category
Incubator
Profile
/france/incubator/station-f
Similar entries
Matched by sector and location overlapBioptimus
Paris, France · StartupBioptimus is the self-proclaimed "Mistral of Biology," spun out in early 2024 by a team of alumni from Google DeepMind and Owkin, including CEO Jean-Philippe Vert. The company is building what it calls the first universal foundation model for biology. Where large language models were trained on text to learn human language, Bioptimus trains on biological data—DNA sequences, protein structures, cellular imagery, and clinical phenotypes—to infer the underlying rules of life. The ambition is not just better predictions but a unified biological reasoning layer that can simulate outcomes before expensive lab work happens. By 2026, Bioptimus has moved from a research thesis to early commercial traction. After a $41M Series A in 2025, the company released its first commercial model that can predict how a specific molecule will interact with a human cell with unusually high accuracy. This enables in-silico screening that reduces wet-lab costs and improves hit rates for drug discovery. French pharma leaders such as Sanofi have begun using these models to prioritize compounds and compress early-stage discovery timelines. The product value is immediate: fewer failed experiments, faster candidate selection, and deeper mechanistic insight. Bioptimus' roadmap focuses on "multi-scale biology," connecting the micro level (genomics and proteomics) to the macro level (patient outcomes and clinical data). Rather than being limited to protein folding, the models aim to bridge across data modalities so a genetic mutation can be linked to disease pathways, tissue behavior, and potential therapeutic interventions. This requires data breadth and regulatory trust, and Bioptimus is building a defensive moat through European data sovereignty. It leverages partnerships with European research hospitals and biobanks to access high-quality patient data that is difficult for US competitors to acquire under GDPR constraints. That compliance burden becomes a competitive advantage: safer access, better provenance, and stronger alignment with European health data governance. The company remains deeply embedded in the Paris ecosystem. It was incubated inside Owkin before spinning out, maintains a presence around Station F, and benefits from the cross-pollination between French AI and biotech communities. Its investor base reflects that positioning: Sofinnova Partners, Bpifrance, Cathay Innovation, Xavier Niel, and Frst provide a blend of life-science expertise, sovereign capital, and deep-tech conviction. In 2026, Bioptimus is the clearest European bet that foundation models can unlock biology at scale—and a contender to become the default AI layer for drug discovery in Europe.
StartupGrowthBiotechAIHealthcare
BlaBlaCar
Paris, France · StartupBlaBlaCar is the world’s leading long-distance carpooling platform, often hailed as France’s flagship startup success. Founded in 2006 by Frédéric Mazzella (along with Francis Nappez and Nicolas Brusson), BlaBlaCar was born from Mazzella’s realization that countless car journeys had empty seats. The platform (named after users’ self-described chattyness level – “Bla”, “BlaBla”, or “BlaBlaBla”) connects drivers with spare seats to passengers traveling the same way, so they can share the ride and costs. Today, BlaBlaCar has a 100 million-member community across 22+ countries, serving over 25 million travelers per quarter pre-pandemic. It operates in most of Europe and parts of Latin America and Asia, having successfully localized carpooling in markets like Germany, Russia, Brazil, and Turkey. The company also branched into bus travel: in 2018, BlaBlaCar acquired Ouibus from SNCF, rebranding it BlaBlaBus, to offer intercity bus routes alongside carpool rides. BlaBlaCar’s business model charges a roughly 10–20% booking fee from passengers in mature markets, though in new markets it often launches free to build liquidity. Known for its strong community culture, BlaBlaCar emphasizes trust – it introduced verified profiles, ratings, and even an optional “Ladies Only” carpool option. The company achieved unicorn status in 2015 when it raised $200 million at a $1.6 billion valuation and later was valued around $2 billion. Despite the pandemic’s impact on travel, BlaBlaCar rebounded by 2022, even reporting profitability. In 2023, it raised €100 million in financing to fuel growth. BlaBlaCar is often cited in case studies (Harvard, etc.) as a pioneer of the sharing economy in Europe, proving that a people-powered platform can transform intercity transport. By bringing cost-effective travel to millions and fostering new friendships on the road, BlaBlaCar has truly brought “ridesharing” into the mainstream – and stands as one of Europe’s few consumer-tech unicorns with global reach.
StartupGrowthMobilityMarketplace
Brevo
Paris, France · StartupMarketing automation and CRM platform (formerly Sendinblue) with a large London presence and strong SMB community ties.
StartupGrowthMarketingSaaSSMB
Doctolib
Paris, France · StartupHealthtech leader with a major Berlin office and a leading position in Germany’s healthcare market.
StartupGrowthHealthtechSoftware
H
Paris, France · StartupH (formerly Holistic) represents France’s second-wave AI builders: less focused on text generation and more focused on action. Founded in 2024 by a team that included former DeepMind researchers such as Charles Kantor and Laurent Sifre, the company drew attention with a seed round that eclipsed prior European records, signaling investor appetite for agentic AI. H’s core thesis is that the next leap is not bigger language models but AI systems that can plan, execute, and verify multi-step workflows across real software interfaces. The company frames this as “RPA 2.0,” using vision-language models to interact with screens and applications rather than brittle scripts and APIs. The firm’s early months were turbulent, including leadership turnover in late 2024, but the product roadmap accelerated. In November 2025 H launched Runner H, a vision-language agent that can see a desktop and operate mouse and keyboard actions to complete tasks such as booking travel, compiling invoices, or processing customer tickets. The release of Surfer-H-CLI soon after gave developers a programmable surface for building web agents, which helped H win mindshare with the European developer community. An acquisition of Mithril Security in 2025 signaled a focus on secure, private agent deployment — a crucial requirement for enterprise adoption, where the biggest fear is an autonomous agent mishandling data or credentials. H is deeply embedded in the Paris AI ecosystem, with early incubation support from Aglae Ventures and strong ties to the Paris AI Hub around Sorbonne and Ecole Polytechnique. Its backers read like a who’s-who of strategic supporters: Accel led financing, Eric Schmidt invested personally, and strategic relationships with Amazon and UiPath position H as a bridge between cloud infrastructure and automation workflows. French tech patrons Xavier Niel and Bernard Arnault provide both capital and political signal value. By early 2026, H is widely watched as a potential category leader in action-oriented AI, competing to become the default “application layer” for autonomous digital workers across Europe’s enterprises.
StartupSeedAIAutomationEnterprise Software
Comments
New comments are moderated before publishingChecking login status...
Loading comments...